Profiling patent compounds in lipid nanoparticle formulations of siRNA
Lipid nanoparticles (LNPs) have emerged as a prominent delivery system for nucleic acid drugs, attracting significant attention, especially through the successful development of several commercial products. As a key component in LNPs, cationic lipids have long served as a key technical barrier to bl...
Saved in:
Main Authors: | , , , , , |
---|---|
格式: | 圖書 |
出版: |
Elsevier,
2024-12-01T00:00:00Z.
|
主題: | |
在線閱讀: | Connect to this object online. |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
成為第一個發表評論!